Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 11—November 2025

Research Letter

Human Infection with Avian Influenza A(H10N3) Virus, China, 2024

Jing Wang1, Fuyin Bi1, Xiaojuan Luo, Hang Huang, Changwei Liang, Ying Zhao, Weitao He, Ning Kang, Jing Wang, Yu Ju, and Guanghua LanComments to Author 
Author affiliation: Guangxi Center for Disease Prevention and Control, Nanning, China (J. Wang, F. Bi, X. Luo, H. Huang, W. He, N. Kang, J. Wang, Y. Ju, G. Lan); Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning (J. Wang, Y. Ju, G. Lan); Nanning Center for Disease Prevention and Control, Nanning (C. Liang); The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning (Y. Zhao)

Main Article

Figure 1

Timeline of disease progression and treatment history in a case of human infection with avian influenza A(H10N3) virus, China, 2024. BALF, bronchoalveolar lavage fluid; RICU, respiratory intensive care unit; RT-PCR, reverse transcription PCR; VV-ECMO, venovenous extracorporeal membrane oxygenation.

Figure 1. Timeline of disease progression and treatment history in a case of human infection with avian influenza A(H10N3) virus, China, 2024. BALF, bronchoalveolar lavage fluid; RICU, respiratory intensive care unit; RT-PCR, reverse transcription PCR; VV-ECMO, venovenous extracorporeal membrane oxygenation.

Main Article

1These authors contributed equally to this article.

Page created: September 23, 2025
Page updated: November 14, 2025
Page reviewed: November 14, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external